Eddie Albers
US Life Sciences Practice Leader
-
United States
Innovation and advances in biotechnology are helping to prepare for and meet society’s most pressing challenges. The biotech industry’s critical response to the COVID-19 pandemic has underscored the crucial role of biotechnology in our lives.
While the biotech industry is no stranger to multiple threats, the risks are evolving. Marsh offers solutions to help protect companies across the biotech landscape — from large global enterprises to small specialty and “incubator” firms. We focus on your most critical concerns, including:
Biotechnology companies must not only manage current threats, but also look ahead to emerging risks that could affect their operations. Incorporating industry leading data and analytics, Marsh’s industry specialists work with you to develop and implement a robust plan and strategy tailored to your unique needs.
US biotech firms have a unique risk profile and can benefit from a multi-step approach to managing risk. Best practices commonly include:
Marsh’s industry specialists have extensive experience helping companies like yours. Our data-driven approach can help you select the most appropriate plans, processes, and procedures for your organization, allowing you to better prepare for adverse events.
US Life Sciences Practice Leader
United States